{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/8cf4cec7-5a0f-49c5-8ec9-36941b5c6b6e/6453e4356868b8001133bd88?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Loyal's Celine Halioua: \"The first life extension drug for dogs\" ","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/61ba0b311a8cbef1d93cf121/show-cover.jpg?height=200","description":"<p>The Sunday Times’ tech correspondent Danny Fortson brings on Loyal founder Celine Halioua, to talk about extending the life of dogs (3:00), pushing to get first product on market in 2025 (6:10), the regulatory path (10:40), growing up in Texas (15:40), how health anxiety seeded her passion for longevity science (21:00), leaving Oxford after being sexually harassed (25:10), coming to San Francisco to work with Laura Deming on longevity (28:50), choosing to work on dogs (31:30), raising money (39:35), convincing top people to join Loyal (42:30), the development timeline (47:00), and the future of longevity science (50:45).</p>","author_name":"The Sunday Times"}